Total Valuation
Recordati Industria Chimica e Farmaceutica SPA has a market cap or net worth of $12.26B. The enterprise value is $12.60K.
Market Cap$12.26B
Enterprise Value$12.60K
Share Statistics
Recordati Industria Chimica e Farmaceutica SPA has 209,125,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding209,125,150
Owned by Insiders0.24%
Owned by Institutions―
Financial Efficiency
Recordati Industria Chimica e Farmaceutica SPA’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 12.11%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)12.11%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee557.10K
Profits Per Employee94.39K
Employee Count4,700
Asset Turnover0.50
Inventory Turnover1.54
Valuation Ratios
The current PE Ratio of Recordati Industria Chimica e Farmaceutica SPA is 21.3. Recordati Industria Chimica e Farmaceutica SPA’s PEG ratio is 3.24.
PE Ratio21.3
PS Ratio3.81
PB Ratio5.20
Price to Fair Value5.20
Price to FCF19.49
Price to Operating Cash Flow16.30
PEG Ratio3.24
Income Statement
In the last 12 months, Recordati Industria Chimica e Farmaceutica SPA had revenue of 2.62B and earned 443.62M in profits. Earnings per share was 2.16.
Revenue2.62B
Gross Profit1.79B
Operating Income719.74M
Pretax Income581.27M
Net Income443.62M
EBITDA887.00M
Earnings Per Share (EPS)2.16
Cash Flow
In the last 12 months, operating cash flow was 644.69M and capital expenditures -62.85M, giving a free cash flow of 581.83M billion.
Operating Cash Flow644.69M
Free Cash Flow581.83M
Free Cash Flow per Share2.78
Dividends & Yields
Recordati Industria Chimica e Farmaceutica SPA pays an annual dividend of $0.824, resulting in a dividend yield of 2.75%
Dividend Per Share$0.824
Dividend Yield2.75%
Payout Ratio46.06%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.39
52-Week Price Change4.57%
50-Day Moving Average58.81
200-Day Moving Average56.92
Relative Strength Index (RSI)46.52
Average Volume (3m)0.00
Important Dates
Recordati Industria Chimica e Farmaceutica SPA upcoming earnings date is Nov 10, 2026, TBA (Confirmed).
Last Earnings DateJul 28, 2026
Next Earnings DateNov 10, 2026
Ex-Dividend Date―
Financial Position
Recordati Industria Chimica e Farmaceutica SPA as a current ratio of 1.59, with Debt / Equity ratio of 108.41%
Current Ratio1.59
Quick Ratio1.08
Debt to Market Cap0.24
Net Debt to EBITDA2.30
Interest Coverage Ratio7.25
Taxes
In the past 12 months, Recordati Industria Chimica e Farmaceutica SPA has paid 137.65M in taxes.
Income Tax137.65M
Effective Tax Rate0.24
Enterprise Valuation
Recordati Industria Chimica e Farmaceutica SPA EV to EBITDA ratio is 13.54, with an EV/FCF ratio of 23.47.
EV to Sales4.59
EV to EBITDA13.54
EV to Free Cash Flow23.47
EV to Operating Cash Flow20.13
Balance Sheet
Recordati Industria Chimica e Farmaceutica SPA has $391.38M in cash and marketable securities with $2.31B in debt, giving a net cash position of -$1.92B billion.
Cash & Marketable Securities$391.38M
Total Debt$2.31B
Net Cash-$1.92B
Net Cash Per Share-$9.17
Tangible Book Value Per Share-$6.18
Margins
Gross margin is 70.74%, with operating margin of 27.49%, and net profit margin of 16.94%.
Gross Margin70.74%
Operating Margin27.49%
Pretax Margin22.20%
Net Profit Margin16.94%
EBITDA Margin33.88%
EBIT Margin25.99%
Analyst Forecast
The average price target for Recordati Industria Chimica e Farmaceutica SPA is $57.55, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$57.55
Price Target Upside-2.86% Downside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast17.02%
EPS Growth Forecast32.09%